IGF2BP1 and hepatocellular carcinoma: Zhang et al. found that miR-9 plays a tumor-suppressive role in HCC partially by regulating the IGF2BP1/AKT&ERK (insulin-like growth factor 2 mRNA-binding protein 1/AKT and extracellular signal-regulated kinase) axis 24.